Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1X7S

The X-ray crystallographic structure of the amyloidogenic variant TTR Tyr78Phe

Summary for 1X7S
Entry DOI10.2210/pdb1x7s/pdb
Related1X7T
DescriptorTransthyretin (2 entities in total)
Functional Keywordstransthyretin, familial amyoidotic polyneuropathy, amyloid, transport protein
Biological sourceHomo sapiens (human)
Cellular locationSecreted: P02766
Total number of polymer chains2
Total formula weight27522.72
Authors
Neto-Silva, R.M.,Macedo-Ribeiro, S.,Pereira, P.J.B.,Saraiva, M.J.,Damas, A.M. (deposition date: 2004-08-16, release date: 2005-03-22, Last modification date: 2023-08-23)
Primary citationNeto-Silva, R.M.,Macedo-Ribeiro, S.,Pereira, P.J.,Coll, M.,Saraiva, M.J.,Damas, A.M.
X-ray crystallographic studies of two transthyretin variants: further insights into amyloidogenesis.
Acta Crystallogr.,Sect.D, 61:333-339, 2005
Cited by
PubMed Abstract: Transthyretin (TTR) is a homotetrameric plasma protein that, as a result of a set of not yet fully characterized conformational changes, forms fibrillar aggregates that are the major protein component of amyloid deposits. More than 80 mutations associated with TTR amyloid deposition have been described in the literature. X-ray crystallography was used to elucidate the three-dimensional structure of two important TTR variants: TTR Y78F, an amyloidogenic protein, and TTR R104H, which is associated with a protective effect over the amyloidogenic V30M mutation. The structures of those two TTR variants have been determined in space group P2(1)2(1)2 to 1.55 and 1.60 angstroms resolution, respectively, using molecular-replacement techniques. Detailed analysis of the protein model for TTR Y78F indicates a destabilization of the contacts between the alpha-helix and AB loop and the body of the molecule, intimately related to the amyloidogenic nature; contrastingly, in the TTR R104H variant new contacts involving the N-terminal region and His104 are clearly antagonists of amyloid formation.
PubMed: 15735344
DOI: 10.1107/S0907444904034316
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.55 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon